<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Malar.</journal-id>
<journal-title>Frontiers in Malaria</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Malar.</abbrev-journal-title>
<issn pub-type="epub">2813-7396</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fmala.2024.1362644</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Malaria</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Optical tweezers to measure the elasticity of red blood cells: a tool to study the erythrocyte response to antimalarials</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Dorta</surname>
<given-names>Doriana</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Padmore</surname>
<given-names>Patrick</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Correa</surname>
<given-names>Ricardo</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1909524"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pineda</surname>
<given-names>Laura</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Spadafora</surname>
<given-names>Carmenza</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/827150"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sarmiento-G&#xf3;mez</surname>
<given-names>Erick</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/788196"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Coronado</surname>
<given-names>Lorena M.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1606851"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Biomedical Physics and Engineering Unit, Center of Cellular and Molecular Biology of Diseases (CBCMe), Instituto de Investigaciones Cient&#xed;ficas y Servicios de Alta Tecnolog&#xed;a (INDICASAT AIP)</institution>, <addr-line>Panama City</addr-line>, <country>Panama</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Sistema Nacional de Investigaci&#xf3;n, Secretar&#xed;a Nacional de Ciencia, Tecnolog&#xed;a e Innovaci&#xf3;n</institution>, <addr-line>Panama City</addr-line>, <country>Panama</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Divisi&#xf3;n de Ciencias e Ingenier&#xed;a, Universidad de Guanajuato</institution>, <addr-line>Le&#xf3;n</addr-line>, <country>Mexico</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Alena Pance, University of Hertfordshire, United Kingdom</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Viola Introini, European Molecular Biology Laboratory, Spain</p>
<p>Jessica Molina-Franky, Beckman Research Institute, City of Hope, United States</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Lorena M. Coronado, <email xlink:href="mailto:lcoronado@indicasat.org.pa">lcoronado@indicasat.org.pa</email>
</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>28</day>
<month>03</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>2</volume>
<elocation-id>1362644</elocation-id>
<history>
<date date-type="received">
<day>28</day>
<month>12</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>01</day>
<month>03</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Dorta, Padmore, Correa, Pineda, Spadafora, Sarmiento-G&#xf3;mez and Coronado</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Dorta, Padmore, Correa, Pineda, Spadafora, Sarmiento-G&#xf3;mez and Coronado</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>The <italic>Plasmodium falciparum</italic> parasite infected more than 240 million people and killed around 600,000 patients last year alone. A key aspect of the pathophysiology of <italic>P. falciparum</italic> is the increased rigidity and adhesiveness of the membrane of infected red blood cells (iRBC). Optical tweezers (OT) have been proposed as a tool to evaluate and screen potential drugs because they can provide valuable information to determine a drug&#x2019;s mechanism of action. The OT experimental design of this study was used to compare the plasma membrane stiffness of uninfected RBCs (uRBCs) and iRBCs, showing that the iRBCs were four times more rigid. The increased rigidity was more evident in those RBCs infected by the <italic>P. falciparum</italic> schizont stage. We also characterized the membrane deformability of iRBCs <italic>in vitro</italic> under the active concentration of common antimalarials on drug-resistant and non-drug-resistant <italic>P. falciparum</italic> strains. In addition, we also determined that the increased membrane rigidity of uRBCs during <italic>P. falciparum</italic> infection, known as the bystander effect, is partially reversed by antimalarial drugs. These findings suggest that single-cell mechanical measurements have potential uses in personalized medicine by characterizing the response to malaria treatment.</p>
</abstract>
<kwd-group>
<kwd>malaria</kwd>
<kwd>
<italic>Plasmodium falciparum</italic>
</kwd>
<kwd>optical tweezers</kwd>
<kwd>spring constant (<italic>K</italic>)</kwd>
<kwd>rigidity</kwd>
<kwd>cell membrane</kwd>
<kwd>antimalarials</kwd>
</kwd-group>
<counts>
<fig-count count="7"/>
<table-count count="5"/>
<equation-count count="2"/>
<ref-count count="33"/>
<page-count count="8"/>
<word-count count="3800"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Pathogenesis</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>Malaria remains the most severe and widespread parasitic disease in the world. Over the centuries, it has spread to 91 countries, costing millions of lives. According to the WHO, in 2022, there were an estimated 249 million malaria cases worldwide. The estimated number of malaria deaths in 2022 stood at 608,000 (<xref ref-type="bibr" rid="B30">World malaria report, 2023</xref>). Despite this alarming scenario, malaria is a preventable and curable disease.</p>
<p>The capacity of red blood cells (RBCs) to deform is essential to pass through tiny capillaries and fulfill the role of oxygen exchange in organisms (<xref ref-type="bibr" rid="B8">Diez-Silva et&#xa0;al., 2010</xref>).</p>
<p>The asexual stages of <italic>P. falciparum</italic> generate significant pathophysiological effects after invading RBCs in the bloodstream, particularly the host cells&#x2019; mechanical properties. Previously, it has been reported that <italic>P. falciparum</italic> provokes modifications in the RBC plasma membrane by increasing the rigidity and cytoadherence. This last modification is thought to prevent the splenic clearance of the rigid RBCs (<xref ref-type="bibr" rid="B18">Maier et&#xa0;al., 2008</xref>; <xref ref-type="bibr" rid="B2">Batchelor et&#xa0;al., 2014</xref>; <xref ref-type="bibr" rid="B21">Nureye and Assefa, 2020</xref>). Therefore, there is an increased interest in studying the characterization of cell deformability to identify unknown biological features and mechanisms during malaria infection. Optical tweezers (OT) is one of the tools used to characterize significant increments in membrane stiffness in both uRBCs and <italic>P. falciparum</italic> iRBCs <italic>in vitro</italic> and <italic>in vivo</italic>. Additionally, this technology has allowed for the identification of the bystander effect, characterized by the presence of a more rigid uRBC after incubation with <italic>P. falciparum</italic> iRBCs (<xref ref-type="bibr" rid="B25">Paul et&#xa0;al., 2013</xref>). Experimental data suggest that ATP and cAMP could mediate this bystander effect (<xref ref-type="bibr" rid="B24">Paul et&#xa0;al., 2017</xref>).</p>
<p>The increased rigidity in the host plasma membrane appears to be dependent on the parasite species and pathobiology&#x2014;for instance, increased membrane rigidity has also been observed in <italic>Plasmodium knowlesi</italic> infection, causing a similar capillary obstruction to that provoked by <italic>P. falciparum</italic> infection (<xref ref-type="bibr" rid="B20">Miller et&#xa0;al., 1971</xref>). The bystander effect was also identified in non-infected cells from patients infected with <italic>P. vivax</italic>, showing a similar outcome to that observed in <italic>P. falciparum</italic> cultures (<xref ref-type="bibr" rid="B14">Huang et&#xa0;al., 2013</xref>; <xref ref-type="bibr" rid="B6">Deng et&#xa0;al., 2015</xref>). Nevertheless, different studies have shown discrepancies between <italic>P. vivax</italic> and infected host cell deformability data. Initially, both <xref ref-type="bibr" rid="B12">Handayani et&#xa0;al. (2008)</xref> and <xref ref-type="bibr" rid="B19">Malleret et&#xa0;al. (2015)</xref> reported an increment in the deformation capacity of infected reticulocytes. Other studies identified an increment in the corner frequency of the circulating RBCs from human patients, meaning that host cells became more rigid during infection. However, they clarified that the study did not consider whether the analyzed RBCs were infected or not nor the maturity of the erythrocytes (<xref ref-type="bibr" rid="B16">Jayavanth et&#xa0;al., 2004</xref>; <xref ref-type="bibr" rid="B33">Zhang et&#xa0;al., 2016</xref>).</p>
<p>On the other hand, two different microfluidic devices used by Huang et&#xa0;al. and Deng et&#xa0;al. showed that <italic>P. falciparum</italic> iRBCs that were exposed to cytotoxic drugs often trigger a dynamic process of cytoskeleton reorganization, affecting the RBC mechanical properties (<xref ref-type="bibr" rid="B14">Huang et&#xa0;al., 2013</xref>; <xref ref-type="bibr" rid="B6">Deng et&#xa0;al., 2015</xref>). Few studies have evaluated the effect of drugs using OT technology to identify the structural changes or mechanisms of action against malaria parasites. Therefore, we here present the utilization of OT to study <italic>in vitro</italic> the deformability of <italic>P. falciparum</italic> iRBCs treated with the most common antimalarials. In addition, we also examine the bystander and the drug effects on uRBCs <italic>in vitro</italic>.</p>
</sec>
<sec id="s2" sec-type="results">
<label>2</label>
<title>Results</title>
<sec id="s2_1">
<label>2.1</label>
<title>Optical tweezer device detects parasite-stage-related rigidification in <italic>P. falciparum</italic> iRBC</title>
<p>A commercial OT device measured the plasma membrane rigidity in uRBCs and synchronized iRBCs in the ring and schizont stages of <italic>P. falciparum</italic>. These measurements were based on the mean of the cell membrane spring constant (<italic>K</italic>), defined as the relation between the force applied to the cell membrane and the resulting cell elongation.</p>
<p>Our initial results showed that the stretching force applied to iRBCs increases proportionally to the parasite stage. Consequently, as parasites grow within RBCs, more force is needed to elongate them to the same degree as uRBCs or iRBCs in the early stages. The OT measurement showed that changes in cell elongation of uRBCs by forces as small as 15 pN could be detected. However, iRBCs in the ring and schizont stages required greater force magnitudes to reach similar deformation distances at 50 and 80 pN, respectively (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>).</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Optical images of <bold>(A)</bold> uRBCs at 0, 15.5 39.4 and 102.1pN of tensile forces, <bold>(B)</bold> ring stage at 0, 17, 51 and 65pN of tensile forces and <bold>(C)</bold> schizont stage at 0, 14.7, 54.2 and 81.3 pN of tensile forces by optical tweezers. Red arrows show the laser position in the optical trap at the elongation moment.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmala-02-1362644-g001.tif"/>
</fig>
<p>On the other hand, the average spring constant for uRBCs was 20.65pN/&#x3bc;m, while iRBCs in the ring and schizont stages were 39.46 and 82.33pN/&#x3bc;m, respectively (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2</bold>
</xref>). These results also showed a significant stage-dependent iRBC rigidification in the schizont stage (<italic>p</italic> =&lt;0.0001) and in the ring stage (<italic>p</italic> = 0.0428) in comparison with uRBCs (<xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>). The values for uRBCs were in accordance with previous reports using OT (<xref ref-type="bibr" rid="B5">Dao et&#xa0;al., 2003</xref>; <xref ref-type="bibr" rid="B31">Yoon et&#xa0;al., 2008</xref>).</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Spring constant (<italic>K</italic>) of iRBCs in each parasite developmental stage. Each point represents the spring constant (<italic>K</italic>) for one individual cell. One-way ANOVA. *<italic>p</italic> = 0.0428, ****<italic>p</italic>&lt; 0.0001.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmala-02-1362644-g002.tif"/>
</fig>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>Individual stiffness values of HB3 <italic>P. falciparum</italic> in different parasite stages (ring and schizont) normalized to uRBC cell control.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="center">Parasite stage</th>
<th valign="top" align="center">Median <break/>normalized stiffness</th>
<th valign="top" align="center">Increase in stiffness<break/>(%), median</th>
<th valign="top" align="center">
<italic>P</italic> value</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="center">
<bold>Ring</bold>
</td>
<td valign="top" align="center">1.91</td>
<td valign="top" align="center">91.09</td>
<td valign="top" align="right">0.0428</td>
</tr>
<tr>
<td valign="top" align="center">
<bold>Schizont</bold>
</td>
<td valign="top" align="center">3.99</td>
<td valign="top" align="center">298.69</td>
<td valign="top" align="right">&lt;0.0001</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s2_2">
<label>2.2</label>
<title>Changes in cell membrane rigidity following treatment with a panel of conventional anti-malarial compounds</title>
<p>The difference in RBC stiffness was also examined following treatment with standard drugs. We chose to use mefloquine (MQ), chloroquine (CQ), artemisinin (ART), and pyrimethamine (PYR) in a concentration four times greater than their established EC50 for 4&#xa0;h (<xref ref-type="table" rid="T2">
<bold>Table&#xa0;2</bold>
</xref>). For this study, uRBCs from the same donor were evaluated with each antimalarial compound to determine whether the observed effects were specific to iRBCs. Interestingly, no antimalarial drug significantly altered the uRBCs&#x2019; rigidity (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure S1</bold>
</xref>).</p>
<table-wrap id="T2" position="float">
<label>Table&#xa0;2</label>
<caption>
<p>Drug concentrations and stiffness values of schizont-stage HB3 <italic>P. falciparum</italic> normalized to DMSO control in each anti-malarial drug treatment.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="center">Drug</th>
<th valign="top" align="center">Concentration</th>
<th valign="top" align="center">Median normalized <break/>stiffness</th>
<th valign="top" align="center">Increase in stiffness (%), median</th>
<th valign="top" align="center">
<italic>P</italic> value</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="center">
<bold>Mefloquine (MQ)</bold>
</td>
<td valign="top" align="center">1 &#x3bc;M</td>
<td valign="top" align="center">1.38</td>
<td valign="top" align="center">39</td>
<td valign="top" align="center">0.0308</td>
</tr>
<tr>
<td valign="top" align="center">
<bold>Chloroquine (CQ)</bold>
</td>
<td valign="top" align="center">1 &#x3bc;M</td>
<td valign="top" align="center">1.17</td>
<td valign="top" align="center">18</td>
<td valign="top" align="center">ns</td>
</tr>
<tr>
<td valign="top" align="center">
<bold>Artemisinine (ART)</bold>
</td>
<td valign="top" align="center">20 nM</td>
<td valign="top" align="center">2.02</td>
<td valign="top" align="center">103</td>
<td valign="top" align="center">0.0001</td>
</tr>
<tr>
<td valign="top" align="center">
<bold>Pyrimethamine (PYR)</bold>
</td>
<td valign="top" align="center">20 nM</td>
<td valign="top" align="center">0.93</td>
<td valign="top" align="center">-7</td>
<td valign="top" align="center">ns</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>ns: not statistically significant.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>It is worth noting that MQ, CQ, and ART increased the rigidity of the plasma membrane of iRBCs with schizonts. Still only MQ (<italic>p</italic> = 0.03) and ART (<italic>p</italic>&lt; 0.0001) showed significant differences in the spring constant compared to untreated controls (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3</bold>
</xref>, <xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>). In contrast, PYR decreased stiffness by 7% (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3</bold>
</xref>, <xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>).</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Purified trophozoites (iRBC) were incubated with various antimalarial compounds for 4&#xa0;h. Each point represents the spring constant (<italic>K</italic>) for one trophozoite iRBC. A significant increase in <italic>K</italic> was observed with MQ and ART at 1 &#xb5;M and 20 nM, respectively, compared to untreated DMSO control without drug (w/o drug). One-way ANOVA with multiple comparisons. ****<italic>p</italic>&lt; 0.0001; *<italic>p</italic> = 0.0308.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmala-02-1362644-g003.tif"/>
</fig>
<p>We also tested the effect of CQ on synchronized iRBCs in the ring stage since CQ has the most antimalarial activity in this stage (<xref ref-type="bibr" rid="B32">Zhang et&#xa0;al., 1986</xref>). In this situation, membrane stiffness was also significantly augmented in comparison with the untreated control (<italic>p</italic> = 0.03, <xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4</bold>
</xref>).</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>
<bold>(A)</bold> Purified trophozoites (iRBC) were incubated with CQ for 4&#xa0;h. <bold>(B)</bold> Synchronized rings (iRBC) were incubated with CQ for 4&#xa0;h. Each point represents the spring constant (<italic>K</italic>) for one iRBC. A significant increase in <italic>K</italic> was observed with CQ in the ring stage compared to untreated DMSO control without drug (w/o drug). <italic>T</italic>-test. *<italic>p</italic> = 0.0376.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmala-02-1362644-g004.tif"/>
</fig>
</sec>
<sec id="s2_3">
<label>2.3</label>
<title>Changes in cell membrane rigidity in PYR-resistant and PYR-susceptible strains</title>
<p>Our initial data showed that PYR-resistant HB3 presented a 7% decrease in stiffness of the RBC plasma membrane. Previously, it was reported that the HB3 strain is susceptible to almost all antimalarial drugs except pyrimethamine (<xref ref-type="bibr" rid="B22">Nzila and Mwai, 2010</xref>). Therefore, we also assessed the rigidity of the cell membrane after treatment with PYR on the 3D7 strain, a <italic>P. falciparum</italic> strain reported to be susceptible to PYR. Remarkably, the membrane rigidity of RBCs in <italic>P. falciparum</italic> 3D7 samples treated with PYR was 26% higher than that of the untreated group (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5</bold>
</xref>).</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>Purified trophozoites (iRBC) from HB3 strain <bold>(A)</bold> and 3D7 strain <bold>(B)</bold> were incubated with PYR for 4&#xa0;h. Each point represents the spring constant (<italic>K</italic>) for one iRBC. A significant increase in <italic>K</italic> was observed with PYR in the 3D7 strain compared to untreated DMSO control without drug (w/o drug). <italic>T</italic>-test. *<italic>p</italic> = 0.04.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmala-02-1362644-g005.tif"/>
</fig>
<p>Furthermore, we determined that changes in cell membrane rigidity depended on the strain&#x2019;s sensitivity to drugs. In the case of the HB3 strain, with an experimental IC<sub>50</sub> of 68.7 &#x3bc;M to PYR, no significant changes were detected in cell membrane rigidity, with a median deformability of 0.93. In contrast, the PYR-sensitive 3D7 strain (IC<sub>50</sub>&#xa0;=&#xa0;8 nM) showed a significantly increased stiffness after drug treatment with a median deformability of 1.26 and <italic>p</italic> = 0.04. Individual concentrations and stiffness values were normalized to DMSO control (<xref ref-type="table" rid="T3">
<bold>Table&#xa0;3</bold>
</xref>).</p>
<table-wrap id="T3" position="float">
<label>Table&#xa0;3</label>
<caption>
<p>Stiffness value of the schizont stage of HB3 and 3D7 <italic>P. falciparum</italic> strains normalized to DMSO control in pyrimethamine treatment at 20 nM.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="center">
<italic>P. falciparum</italic> strain</th>
<th valign="top" align="center">PYR concentration</th>
<th valign="top" align="center">Experimental PYR IC<sub>50</sub>
</th>
<th valign="top" align="center">Median <break/>normalized stiffness</th>
<th valign="top" align="center">Increase in <break/>stiffness(%), median</th>
<th valign="top" align="center">
<italic>P</italic> value</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="center">
<bold>HB3</bold>
</td>
<td valign="top" align="center">20 nM</td>
<td valign="top" align="center">68.7 &#x3bc;M</td>
<td valign="top" align="center">0.93</td>
<td valign="top" align="center">-7</td>
<td valign="top" align="center">ns</td>
</tr>
<tr>
<td valign="top" align="center">
<bold>3D7</bold>
</td>
<td valign="top" align="center">20 nM</td>
<td valign="top" align="center">8 nM</td>
<td valign="top" align="center">1.26</td>
<td valign="top" align="center">26</td>
<td valign="top" align="center">0.04</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>ns: not statistically significant.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s2_4">
<label>2.4</label>
<title>Measurable changes in membrane rigidity caused by bystander effect in response to antimalarial drugs</title>
<p>To assess the bystander effect, we first measured the stiffness of uRBCs from two independent <italic>in vitro</italic> cultures infected with HB3 and 3D7 strains, which were synchronized at the schizont stage. Then, we compared these measurements with a uRBC culture from the same donor but without the prior presence of parasites. We determined that the spring constant in uRBCs from HB3 and 3D7 cultures was 29% and 35% greater, respectively, than for those that had never been in contact with parasites (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6</bold>
</xref>, <xref ref-type="table" rid="T4">
<bold>Table&#xa0;4</bold>
</xref>).</p>
<fig id="f6" position="float">
<label>Figure&#xa0;6</label>
<caption>
<p>Bystander effect. <bold>(A)</bold> Spring constant (<italic>K</italic>) of uRBC from an <italic>in vitro</italic> culture infected with HB3 strain. <bold>(B)</bold> Spring constant (<italic>K</italic>) of uRBC from an <italic>in vitro</italic> culture infected with 3D7 strain. A uRBC culture from the same donor without previous parasite contact was used as control. The bars represent the mean &#xb1; SEM values. <italic>T</italic>-test. *<italic>p</italic> = 0.04.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmala-02-1362644-g006.tif"/>
</fig>
<table-wrap id="T4" position="float">
<label>Table&#xa0;4</label>
<caption>
<p>Individual stiffness value of uRBCs from two independent <italic>in vitro</italic> cultures infected with HB3 and 3D7 strains normalized to uRBC culture from the same donor without a previous parasite contact.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="center">Strain</th>
<th valign="top" align="center">Median <break/>normalized stiffness</th>
<th valign="top" align="center">Increase in <break/>stiffness<break/>(%), median</th>
<th valign="top" align="center">
<italic>P</italic> value</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="center">
<bold>HB3</bold>
</td>
<td valign="top" align="center">1.26</td>
<td valign="top" align="center">26.11</td>
<td valign="top" align="center">0.04</td>
</tr>
<tr>
<td valign="top" align="center">
<bold>3D7</bold>
</td>
<td valign="top" align="center">1.47</td>
<td valign="top" align="center">47.14</td>
<td valign="top" align="center">0.04</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>After that, we evaluated the effect of MQ, CQ, ART, and PYR in those uRBC cultures that were previously exposed to iRBCs in a standard <italic>in vitro</italic> culture. As a control, we measured the stiffness of uRBCs treated with the same drugs and cultured without <italic>P. falciparum</italic> parasites. The measurement by OT showed that the stiffness dropped by 18%, 28%, 25%, and 14% after being exposed to MQ, CQ, ART, and PYR, respectively, though only with statistical significance for CQ (<italic>p</italic> = 0.03) and ART (<italic>p</italic> = 0.0090) (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7</bold>
</xref>, <xref ref-type="table" rid="T5">
<bold>Table&#xa0;5</bold>
</xref>).</p>
<fig id="f7" position="float">
<label>Figure&#xa0;7</label>
<caption>
<p>Bystander effect in response to antimalarials. Spring constant (<italic>K</italic>) of uRBC from an <italic>in vitro</italic> culture infected with HB3 strain in response to treatment with antimalarials for 4&#xa0;h. The bars represent mean &#xb1; SEM. One-way ANOVA with multiple comparisons. *<italic>p</italic> = 0.03; **<italic>p</italic> = 0.009.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmala-02-1362644-g007.tif"/>
</fig>
<table-wrap id="T5" position="float">
<label>Table&#xa0;5</label>
<caption>
<p>Individual stiffness value of uRBCs from <italic>in vitro</italic> culture infected with HB3 strain in response to antimalarial drugs.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="center">Drug</th>
<th valign="top" align="center">Concentration</th>
<th valign="top" align="center">Median normalized stiffness</th>
<th valign="top" align="center">Decrease in stiffness (%),<break/>median</th>
<th valign="top" align="center">
<italic>P</italic> value</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="center">
<bold>Mefloquine (MQ)</bold>
</td>
<td valign="top" align="center">1 &#x3bc;M</td>
<td valign="top" align="center">0.77</td>
<td valign="top" align="center">-22.44</td>
<td valign="top" align="center">ns</td>
</tr>
<tr>
<td valign="top" align="center">
<bold>Chloroquine (CQ)</bold>
</td>
<td valign="top" align="center">1 &#x3bc;M</td>
<td valign="top" align="center">0.70</td>
<td valign="top" align="center">-29</td>
<td valign="top" align="center">0.0314</td>
</tr>
<tr>
<td valign="top" align="center">
<bold>Artemisinine (ART)</bold>
</td>
<td valign="top" align="center">20 nM</td>
<td valign="top" align="center">0.72</td>
<td valign="top" align="center">-27.99</td>
<td valign="top" align="center">0.0090</td>
</tr>
<tr>
<td valign="top" align="center">
<bold>Pyrimethamine (PYR)</bold>
</td>
<td valign="top" align="center">20 nM</td>
<td valign="top" align="center">0.81</td>
<td valign="top" align="center">-18.47</td>
<td valign="top" align="center">ns</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>The values were normalized to uRBC culture from the same donor without previous parasite contact. ns: not statistically significant</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
</sec>
<sec id="s3" sec-type="discussion">
<label>3</label>
<title>Discussion</title>
<p>The increment in <italic>P. falciparum</italic> iRBC membrane stiffness has been known for over 30 years (<xref ref-type="bibr" rid="B27">Paulitschke and Nash, 1993</xref>). In this study, we confirmed that plasma membrane rigidity increased fourfold in iRBCs, depending mainly on the parasite strain and drug sensitivity. Specifically, the stiffness caused by HB3 and 3D7 strains varied differentially after the selected antimalarials were applied to resistant and non-resistant strains.</p>
<p>Previously, <xref ref-type="bibr" rid="B28">Suresh et&#xa0;al. (2005)</xref> demonstrated that the stiffness of iRBCs increased 10-fold compared with uRBCs using OT. In our study, iRBCs exhibited a stiffness four times greater than that of uRBCs. This difference in magnitude between the two studies could have originated in the experimental approach, including the configuration of the OT, bead attachment solutions, and <italic>in vitro</italic> conditions. Nevertheless, both studies reached similar conclusions regarding the changes in RBC rigidity during different malaria parasite stages.</p>
<p>Our OT measurements suggest that the mechanical properties of the HB3 PYR-resistant strain were not affected upon treatment with PYR. However, the plasma membrane of iRBCs showed increased stiffness after using MQ, CQ, and ART on the same HB3 strain. The opposite effect was observed in the case of the PYR-sensitive 3D7 strain (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5</bold>
</xref>). It is worth noting that the antimalarials tested in this study are known to generate oxidative stress on parasites and host cells (<xref ref-type="bibr" rid="B11">Gunjan et&#xa0;al., 2016</xref>; <xref ref-type="bibr" rid="B10">Egwu et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B29">Wagner and Chitnis, 2023</xref>). Previous reports demonstrated that oxidative stress, such as lipid peroxidation, can modify the membrane structure and mechanical properties of living cells (<xref ref-type="bibr" rid="B3">Chng et&#xa0;al., 2021</xref>). Hence, we are tempted to point out that the increased rigidity of iRBCs is probably related to the induction of cell membrane lipid peroxidation. Nevertheless, testing other compounds that do not generate reactive oxygen species is necessary to discard this hypothesis.</p>
<p>We were also able to replicate the bystander effect observed in those uRBCs present in the same <italic>P. falciparum</italic> iRBC <italic>in vitro</italic> culture, showing that those uninfected cells became more rigid after being co-cultured with iRBCs. Notably, the tested antimalarial drugs partially reverted the bystander effect that previously increased the rigidity of uRBCs (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7</bold>
</xref>). This outcome could be part of a secondary unreported benefit of antimalarials on patients by avoiding the premature sequester of uRBCs in the spleen and the associated anemia. This bystander effect may represent a possible explanation for the origin of uRBC hemolysis, which exacerbates anemia during infection, as well as the susceptibility to clogging in arteries and capillaries (<xref ref-type="bibr" rid="B9">Dondorp et&#xa0;al., 1999</xref>). As the rigidity of uRBCs in this phenomenon is mediated primarily by ATP (<xref ref-type="bibr" rid="B26">Paul et&#xa0;al., 2019</xref>), it is plausible that a plasma membrane protein related to ATP could be responsible for the reversal of rigidity attributed to antimalarials. Although very interesting for further experimentation, it is out of the scope of the present work.</p>
<p>This study supports previous reports that identified a lower parasite invasion in patients with Dantu and beta-thalassemia phenotypes, which are known to manifest an irregular deformability of the RBC plasma membrane (<xref ref-type="bibr" rid="B17">Kariuki et&#xa0;al., 2020</xref>; <xref ref-type="bibr" rid="B15">Introini et&#xa0;al., 2022</xref>). Interestingly, a recent report revealed that the antimalarial compound M5717 significantly decreased iRBC rigidity and cytoadherence, provoking a parasite clearance delay in the blood torrent of mice and humans in preclinical and clinical trials. Therefore, we suggest that RBC rigidity may be used as an additional parameter to characterize and optimize drug activity screening before moving to <italic>in vivo</italic> models or preclinical trials (<xref ref-type="bibr" rid="B23">Parkyn Schneider et&#xa0;al., 2023</xref>). Furthermore, this type of information could also be used as a personalized medicine tool by characterizing associated changes in the rigidity of the cell membranes before administering a particular treatment (<xref ref-type="bibr" rid="B7">Di Carlo, 2012</xref>).</p>
</sec>
<sec id="s4" sec-type="materials|methods">
<label>4</label>
<title>Materials and methods</title>
<sec id="s4_1">
<label>4.1</label>
<title>Parasites and culture</title>
<p>The malaria parasite strains HB3 (pyrimethamine-resistant) of <italic>P. falciparum</italic> (a generous gift of the Experimental Therapeutics Division of the Walter Reed Army Institute of Research in Silver Spring, MD) and 3D7 (pyrimethamine-sensitive) (ATCC) were cultivated following the method described by <xref ref-type="bibr" rid="B13">Haynes et&#xa0;al. (1976)</xref>, with some modifications. In brief, we used O+ erythrocytes in a complete medium of RPMI 1640 supplemented with 25 mM HEPES, 0.2% sodium bicarbonate, and 10% human serum. All experiments obtained blood for RBC isolation from a single donor to avoid inter-donor variability. Before blood extraction, the volunteer was required to obtain medical certificates of good health free of medication regimes. The blood was drawn with citrate phosphate dextrose adenine (CPDA) as an anticoagulant at 10% v/v after extraction. The cultures were maintained at 37&#xb0;C in a gas mixture of 5% CO<sub>2</sub>, 5% O<sub>2</sub>, and 90% N<sub>2</sub> at 2% hematocrit and synchronized with alanine and a thermal cycling incubator as described in <xref ref-type="bibr" rid="B1">Almanza et&#xa0;al. (2011)</xref>.</p>
</sec>
<sec id="s4_2">
<label>4.2</label>
<title>Optical tweezers setup</title>
<p>The configuration of the OT (MMI GmbH, Germany) was set on an inverted Olympus IX83 microscope with a &#xd7;100 oil immersion objective. The MBPS2 sensitive position detector and the MMI CellManipulator software were used to control the solid-state laser electronically with a wavelength of 1,070 nm at 8 W.</p>
</sec>
<sec id="s4_3">
<label>4.3</label>
<title>Force calibration and spring constant measurement (<italic>K</italic>)</title>
<p>The optical tweezers must be calibrated each time before measuring the magnitude of the forces acting on the polystyrene particles. Optical stiffness, <italic>K</italic>, was determined by the oscillatory drag force method. For further measurements, forces were calculated for the optical tweezers using Hooke&#x2019;s law:</p>
<disp-formula>
<mml:math display="block" id="M1">
<mml:mrow>
<mml:mi>F</mml:mi>
<mml:mo>=</mml:mo>
<mml:mtext>&#xa0;</mml:mtext>
<mml:mo>&#x2212;</mml:mo>
<mml:mi>K</mml:mi>
<mml:mi>x</mml:mi>
</mml:mrow>
</mml:math>
</disp-formula>
<p>where <italic>K</italic> is the optical stiffness of the trap, and <italic>x</italic> is the displacement from the trap&#x2019;s center (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figures S2, S3</bold>
</xref>).</p>
<p>The <italic>K</italic> constant of each cell was calculated by data analysis through image processing using ImageJ software. The boundary of each cell was detected in each frame for the same group of images. The changes in cell length were used along with the restoring force and Hooke&#x2019;s equation to calculate the <italic>K</italic> constant (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure S4</bold>
</xref>).</p>
</sec>
<sec id="s4_4">
<label>4.4</label>
<title>Sample preparation of healthy erythrocytes</title>
<p>RBC samples were prepared by taking previously processed RBCs. The RBCs were washed twice with PBS and re-suspended in PBS and ACD (citric acid, sodium citrate, and dextrose). Subsequently, polystyrene particles with a diameter of 3 &#x3bc;m, previously washed with PBS and left at 4&#xb0;C for 1&#xa0;h to obtain a better adherence of the particles to the RBC, were added. Then, polystyrene particles were used to deform the selected uRBC or iRBC. OT was used to manipulate the cell only when one bead was attached to the membrane&#x2019;s edge, and the cell&#x2019;s opposite side was attached to the glass plate, allowing stretching without shedding. The experiments were performed in the linear regime, as all deformation vs. force curves present this behavior. The cell also always recovered its initial shape after each stretching (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure S5</bold>
</xref>).</p>
</sec>
<sec id="s4_5">
<label>4.5</label>
<title>Sample preparation of iRBCs and drug treatment</title>
<p>Magnetic columns were used to enrich the population of late-stage parasites following the methodology of <xref ref-type="bibr" rid="B4">Coronado et&#xa0;al. (2013)</xref>. The isolated parasites were washed twice with PBS and diluted in PBS and ACD. Polystyrene particles were added and left at 4&#xb0;C for 1&#xa0;h. Each sample was then visualized under the microscope, and OT stretched the cell.</p>
<p>In the case of the drug-treated group, the samples were incubated previously with concentrations of chloroquine (CQ) 1 &#x3bc;M, mefloquine (MQ) 1 &#x3bc;M, artemisinin (ART) 20 nM, and pyrimethamine at 20 nM for 4&#xa0;h as described previously by <xref ref-type="bibr" rid="B6">Deng et&#xa0;al. (2015)</xref> (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure S6</bold>
</xref>). The samples were incubated at 37&#xb0;C. Posteriorly, polystyrene particles were added and incubated at 4&#xb0;C for 1&#xa0;h. The samples were then placed under the microscope, and the cell was stretched. We also evaluated the bystander effect with the drugs mentioned above using the same conditions and incubation time. For the bystander effect evaluation, uRBCs were in contact with parasites for 48&#xa0;h prior to experimentation, and all assays were performed while the parasites in culture were in schizont stage.</p>
</sec>
<sec id="s4_6">
<label>4.6</label>
<title>Relative deformability calculation</title>
<p>Relative deformability, RD, expresses the deformability of the treated cells, with <italic>D<sub>t</sub>
</italic> normalized to the median deformability of cells in the DMSO control for a given experimental series, <italic>D</italic>
<sub>ctrl</sub>, according to the following formula:</p>
<disp-formula>
<mml:math display="block" id="M2">
<mml:mrow>
<mml:mtext>RD=</mml:mtext>
<mml:mfrac>
<mml:mrow>
<mml:msub>
<mml:mi>D</mml:mi>
<mml:mi>t</mml:mi>
</mml:msub>
</mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mi>D</mml:mi>
<mml:mrow>
<mml:mtext>ctrl</mml:mtext>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
</mml:math>
</disp-formula>
<p>This procedure facilitates the assessment of the effects of treatment on deformability and is easily compared between experiments.</p>
</sec>
<sec id="s4_7">
<label>4.6</label>
<title>Statistical analysis</title>
<p>All experiments were independently repeated at least twice, and 15&#x2013;20 cells were analyzed per sample. The dispersion graphs of all experiments are presented. Statistical analysis was calculated using Prism Gradpad v7 with a <italic>t</italic>-test when comparing one group to another. Multiple comparison analysis was performed with one-way ANOVA. Data were evaluated by analysis of variance, and significant differences between groups were determined using Bonferroni&#x2019;s modification. The relationship between the force applied and the changes in RBC diameter was evaluated by linear regression to calculate the <italic>K</italic> spring constant. <italic>P</italic>&lt; 0.05 was considered statistically significant. Significance was considered as follows: *<italic>p</italic>&lt; 0.05; **<italic>p</italic>&lt; 0.01; ***<italic>p</italic>&lt; 0.005, ****<italic>p</italic>&lt; 0.0001.</p>
</sec>
</sec>
<sec id="s5" sec-type="data-availability">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Material</bold>
</xref>. Further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s6" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>The studies involving humans were approved by Bioethical committee of Universidad Cat&#xf3;lica Santa Mar&#xed;a La Antigua (USMA) in Panama with Number 2023-PO60. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.</p>
</sec>
<sec id="s7" sec-type="author-contributions">
<title>Author contributions</title>
<p>LC: Conceptualization, Data curation, Formal Analysis, Writing&#xa0;&#x2013; review &amp; editing, Writing &#x2013; original draft, Visualization, Validation, Supervision, Software, Resources, Project administration, Methodology, Investigation, Funding acquisition. DD: Conceptualization, Formal Analysis, Investigation, Methodology, Validation, Visualization, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. PP: Writing &#x2013; review &amp; editing, Writing &#x2013; original draft, Methodology, Investigation, Formal Analysis. RC: Writing &#x2013; review &amp; editing, Writing &#x2013; original draft, Supervision, Funding acquisition, Data curation, Conceptualization. LP: Writing &#x2013; review &amp; editing, Writing &#x2013; original draft, Supervision, Investigation. CS: Funding acquisition, Methodology, Resources, Supervision, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. ES-G: Conceptualization, Data curation, Formal Analysis, Methodology, Supervision, Validation, Visualization, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing.</p>
</sec>
</body>
<back>
<sec id="s8" sec-type="funding-information">
<title>Funding</title>
<p>The author(s) declare financial support was received for the research, authorship, and/or publication of this article. Secretar&#xed;a Nacional de Ciencia, Tecnolog&#xed;a e Innovaci&#xf3;n (SENACYT) grant FIED19-R1-007 (LC) and other partial funds from Panama&#x2019;s National Research System (SNI) (LC, RC, and CS). Support also came from SENACYT reinsertion grants (LC and RC).</p>
</sec>
<sec id="s9" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
<p>The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.</p>
</sec>
<sec id="s10" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s11" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fmala.2024.1362644/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fmala.2024.1362644/full#supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet_1.pdf" id="SM1" mimetype="application/pdf"/>
<supplementary-material xlink:href="Video_1.avi" id="SM2" mimetype="video/x-msvideo"/>
<supplementary-material xlink:href="Video_2.avi" id="SM3" mimetype="video/x-msvideo"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Almanza</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Herrera</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Tayler</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Coronado</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Spadafora</surname> <given-names>C.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Automated Synchronization of P. falciparum using a Temperature Cycling Incubator</article-title>. <source>Curr. Trends Biotechnol. Pharm.</source> <volume>5</volume>, <fpage>1130</fpage>&#x2013;<lpage>1133</lpage>.</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Batchelor</surname> <given-names>J. D.</given-names>
</name>
<name>
<surname>Malpede</surname> <given-names>B. M.</given-names>
</name>
<name>
<surname>Omattage</surname> <given-names>N. S.</given-names>
</name>
<name>
<surname>DeKoster</surname> <given-names>G. T.</given-names>
</name>
<name>
<surname>Henzler-Wildman</surname> <given-names>K. A.</given-names>
</name>
<name>
<surname>Tolia</surname> <given-names>N. H.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Red blood cell invasion by Plasmodium vivax: structural basis for DBP engagement of DARC</article-title>. <source>PloS Pathog.</source> <volume>10</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.ppat.1003869</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chng</surname> <given-names>C.-P.</given-names>
</name>
<name>
<surname>Sadovsky</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Hsia</surname> <given-names>K. J.</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>C.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Site-specific peroxidation modulates lipid bilayer mechanics</article-title>. <source>Extrem. Mech. Lett.</source> <volume>42</volume>, <fpage>101148</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.eml.2020.101148</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coronado</surname> <given-names>L. M.</given-names>
</name>
<name>
<surname>Tayler</surname> <given-names>N. M.</given-names>
</name>
<name>
<surname>Correa</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Giovani</surname> <given-names>R. M.</given-names>
</name>
<name>
<surname>Spadafora</surname> <given-names>C.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Separation of Plasmodium falciparum late stage-infected erythrocytes by magnetic means</article-title>. <source>J. Vis. Exp.</source>, <elocation-id>e50342</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3791/50342</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dao</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Lim</surname> <given-names>C. T.</given-names>
</name>
<name>
<surname>Suresh</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Mechanics of the human red blood cell deformed by optical tweezers</article-title>. <source>J. Mech. Phys. Solids</source> <volume>51</volume>, <fpage>2259</fpage>&#x2013;<lpage>2280</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jmps.2003.09.019</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deng</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Duffy</surname> <given-names>S. P.</given-names>
</name>
<name>
<surname>Myrand-Lapierre</surname> <given-names>M. E.</given-names>
</name>
<name>
<surname>Matthews</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Santoso</surname> <given-names>A. T.</given-names>
</name>
<name>
<surname>Du</surname> <given-names>Y. L.</given-names>
</name>
<etal/>
</person-group>. (<year>2015</year>). <article-title>Reduced deformability of parasitized red blood cells as a biomarker for anti-malarial drug efficacy</article-title>. <source>Malar. J.</source> <volume>14</volume>, <fpage>1</fpage>&#x2013;<lpage>9</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12936-015-0957-z</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Di Carlo</surname> <given-names>D.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>A mechanical biomarker of cell state in medicine</article-title>. <source>J. Lab. Autom.</source> <volume>17</volume>, <fpage>32</fpage>&#x2013;<lpage>42</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1177/2211068211431630</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Diez-Silva</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Dao</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Han</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Lim</surname> <given-names>C. T.</given-names>
</name>
<name>
<surname>Suresh</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Shape and biomechanical characteristics of human red blood cells in health and disease</article-title>. <source>MRS Bull.</source> <volume>35</volume>, <fpage>382</fpage>&#x2013;<lpage>388</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1557/mrs2010.571</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dondorp</surname> <given-names>A. M.</given-names>
</name>
<name>
<surname>Angus</surname> <given-names>B. J.</given-names>
</name>
<name>
<surname>Chotivanich</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Silamut</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Ruangveerayuth</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Hardeman</surname> <given-names>M. R.</given-names>
</name>
<etal/>
</person-group>. (<year>1999</year>). <article-title>Red blood cell deformability as a predictor of anemia in severe falciparum malaria</article-title>. <source>Am. J. Trop. Med. Hyg.</source> <volume>60</volume>, <fpage>733</fpage>&#x2013;<lpage>737</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.4269/ajtmh.1999.60.733</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Egwu</surname> <given-names>C. O.</given-names>
</name>
<name>
<surname>Tsamesidis</surname> <given-names>I.</given-names>
</name>
<name>
<surname>P&#xe9;rio</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Augereau</surname> <given-names>J.-M.</given-names>
</name>
<name>
<surname>Benoit-Vical</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Reybier</surname> <given-names>K.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Superoxide: A major role in the mechanism of action of essential antimalarial drugs</article-title>. <source>Free Radic. Biol. Med.</source> <volume>167</volume>, <fpage>271</fpage>&#x2013;<lpage>275</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2021.03.001</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gunjan</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Singh</surname> <given-names>S. K.</given-names>
</name>
<name>
<surname>Sharma</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Dwivedi</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Chauhan</surname> <given-names>B. S.</given-names>
</name>
<name>
<surname>Imran Siddiqi</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2016</year>). <article-title>Mefloquine induces ROS mediated programmed cell death in malaria parasite: Plasmodium</article-title>. <source>Apoptosis</source> <volume>21</volume>, <fpage>955</fpage>&#x2013;<lpage>964</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s10495-016-1265-y</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Handayani</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Chiu</surname> <given-names>D. T.</given-names>
</name>
<name>
<surname>Tjitra</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Kuo</surname> <given-names>J. S.</given-names>
</name>
<name>
<surname>Lampah</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Kenangalem</surname> <given-names>E.</given-names>
</name>
<etal/>
</person-group>. (<year>2008</year>). <article-title>High Deformability of Plasmodium vivax-Infected Red Blood Cells under Microfluidic Conditions</article-title>. doi:&#xa0;<pub-id pub-id-type="doi">10.1086/596048</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haynes</surname> <given-names>J. D.</given-names>
</name>
<name>
<surname>Diggs</surname> <given-names>C. L.</given-names>
</name>
<name>
<surname>Hines</surname> <given-names>F. A.</given-names>
</name>
<name>
<surname>Desjardins</surname> <given-names>R. E.</given-names>
</name>
</person-group> (<year>1976</year>). <article-title>Culture of human malaria parasites Plasmodium falciparum</article-title>. <source>Nature</source> <volume>263</volume>, <fpage>767</fpage>&#x2013;<lpage>769</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/263767a0</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Undisz</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Diez-Silva</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Bow</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Dao</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Han</surname> <given-names>J.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Dynamic deformability of Plasmodium falciparum-infected erythrocytes exposed to artesunate in <italic>vitro</italic>
</article-title>. <source>Integr. Biol. (Camb).</source> <volume>5</volume>, <fpage>414</fpage>&#x2013;<lpage>422</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1039/C2IB20161E</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Introini</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Marin-Menendez</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Nettesheim</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>Y. C.</given-names>
</name>
<name>
<surname>Kariuki</surname> <given-names>S. N.</given-names>
</name>
<name>
<surname>Smith</surname> <given-names>A. L.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>The erythrocyte membrane properties of beta thalassaemia heterozygotes and their consequences for Plasmodium falciparum invasion</article-title>. <source>Sci. Rep.</source> <volume>12</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/S41598-022-12060-4</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jayavanth</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Jagadeesan</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Singh</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Influence of P. vivax malaria on erythrocyte aggregation and deformability</article-title>. <source>Clin. Hemorheol. Microcirc.</source> <volume>31</volume>, <fpage>257</fpage>&#x2013;<lpage>266</lpage>.</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kariuki</surname> <given-names>S. N.</given-names>
</name>
<name>
<surname>Marin-Menendez</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Introini</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Ravenhill</surname> <given-names>B. J.</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>Y. C.</given-names>
</name>
<name>
<surname>Macharia</surname> <given-names>A.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Red blood cell tension protects against severe malaria in the Dantu blood group</article-title>. <source>Nature</source> <volume>585</volume>, <fpage>579</fpage>&#x2013;<lpage>583</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41586-020-2726-6</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maier</surname> <given-names>A. G.</given-names>
</name>
<name>
<surname>Rug</surname> <given-names>M.</given-names>
</name>
<name>
<surname>O&#x2019;Neill</surname> <given-names>M. T.</given-names>
</name>
<name>
<surname>Brown</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Chakravorty</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Szestak</surname> <given-names>T.</given-names>
</name>
<etal/>
</person-group>. (<year>2008</year>). <article-title>Exported proteins required for virulence and rigidity of Plasmodium falciparum-infected human erythrocytes</article-title>. <source>Cell</source> <volume>134</volume>, <fpage>48</fpage>&#x2013;<lpage>61</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cell.2008.04.051</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Malleret</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Tan</surname> <given-names>K. S. W.</given-names>
</name>
<name>
<surname>Suwanarusk</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Claser</surname> <given-names>C.</given-names>
</name>
<etal/>
</person-group>. (<year>2015</year>). <article-title>Plasmodium vivax: restricted tropism and rapid remodeling of CD71-positive reticulocytes</article-title>. <source>Blood</source> <volume>125</volume>, <fpage>1314</fpage>&#x2013;<lpage>1324</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1182/blood-2014-08-596015</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miller</surname> <given-names>L. H.</given-names>
</name>
<name>
<surname>Usami</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Chien</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>1971</year>). <article-title>Alteration in the rheologic properties of Plasmodium knowlesi&#x2013;infected red cells. A possible mechanism for capillary obstruction</article-title>. <source>J. Clin. Invest.</source> <volume>50</volume>, <fpage>1451</fpage>&#x2013;<lpage>1455</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1172/JCI106629</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nureye</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Assefa</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Old and recent advances in life cycle, pathogenesis, diagnosis, prevention, and treatment of malaria including perspectives in Ethiopia</article-title>. <source>Sci. World J.</source> <volume>2020</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2020/1295381</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nzila</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Mwai</surname> <given-names>L.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>
<italic>In vitro</italic> selection of Plasmodium falciparum drug-resistant parasite lines</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>65</volume>, <fpage>390</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/jac/dkp449</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parkyn Schneider</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Looker</surname> <given-names>O.</given-names>
</name>
<name>
<surname>Rebelo</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Khoury</surname> <given-names>D. S.</given-names>
</name>
<name>
<surname>Dixon</surname> <given-names>M. W. A.</given-names>
</name>
<name>
<surname>Oeuvray</surname> <given-names>C.</given-names>
</name>
<etal/>
</person-group>. (<year>2023</year>). <article-title>The delayed bloodstream clearance of Plasmodium falciparum parasites after M5717 treatment is attributable to the inability to modify their red blood cell hosts</article-title>. <source>Front. Cell. Infect. Microbiol.</source> <volume>13</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/FCIMB.2023.1211613/BIBTEX</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paul</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Padmapriya</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Natarajan</surname> <given-names>V.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Diagnosis of malarial infection using change in properties of optically trapped red blood cells</article-title>. <source>Biomed. J.</source> <volume>40</volume>, <fpage>101</fpage>&#x2013;<lpage>105</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.bj.2016.10.001</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paul</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Pallavi</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Tatu</surname> <given-names>U. S.</given-names>
</name>
<name>
<surname>Natarajan</surname> <given-names>V.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>The bystander effect in optically trapped red blood cells due to Plasmodium falciparum infection</article-title>. <source>Trans. R. Soc Trop. Med. Hyg.</source> <volume>107</volume>, <fpage>220</fpage>&#x2013;<lpage>223</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/trstmh/trt010</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paul</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Ramdani</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Tatu</surname> <given-names>U.</given-names>
</name>
<name>
<surname>Langsley</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Natarajan</surname> <given-names>V.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Studying the rigidity of red blood cells induced by Plasmodium falciparum infection</article-title>. <source>Sci. Rep.</source> <volume>9</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/S41598-019-42721-W</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paulitschke</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Nash</surname> <given-names>G. B.</given-names>
</name>
</person-group> (<year>1993</year>). <article-title>Membrane rigidity of red blood cells parasitized by different strains of Plasmodium falciparum</article-title>. <source>J. Lab. Clin. Med.</source> <volume>122</volume>, <fpage>581</fpage>&#x2013;<lpage>589</lpage>.</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suresh</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Spatz</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Mills</surname> <given-names>J. P.</given-names>
</name>
<name>
<surname>Micoulet</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Dao</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Lim</surname> <given-names>C. T.</given-names>
</name>
<etal/>
</person-group>. (<year>2005</year>). <article-title>Connections between single-cell biomechanics and human disease states: gastrointestinal cancer and malaria</article-title>. <source>Acta Biomater.</source> <volume>1</volume>, <fpage>15</fpage>&#x2013;<lpage>30</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.actbio.2004.09.001</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wagner</surname> <given-names>M. P.</given-names>
</name>
<name>
<surname>Chitnis</surname> <given-names>C. E.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Lipid peroxidation and its repair in malaria parasites</article-title>. <source>Trends Parasitol.</source> <volume>39</volume>, <fpage>200</fpage>&#x2013;<lpage>211</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.pt.2022.12.006</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="web">
<person-group person-group-type="author">
<collab>World malaria report</collab>
</person-group> (<year>2023</year>). Available online at: <uri xlink:href="https://www.who.int/publications/i/item/9789240086173">https://www.who.int/publications/i/item/9789240086173</uri> (Accessed <access-date>December 4, 2023</access-date>).</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yoon</surname> <given-names>Y. Z.</given-names>
</name>
<name>
<surname>Kotar</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Yoon</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Cicuta</surname> <given-names>P.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>The nonlinear mechanical response of the red blood cell</article-title>. <source>Phys. Biol.</source> <volume>5</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1088/1478-3975/5/3/036007</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Asante</surname> <given-names>K. S. O.</given-names>
</name>
<name>
<surname>Jung</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>1986</year>). <article-title>Stage-dependent inhibition of chloroquine on Plasmodium falciparum in <italic>vitro</italic>
</article-title>. <source>J. Parasitol.</source> <volume>72</volume>, <fpage>830</fpage>&#x2013;<lpage>836</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.2307/3281830</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>W. C.</given-names>
</name>
<name>
<surname>Lau</surname> <given-names>Y. L.</given-names>
</name>
<name>
<surname>Albrecht</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Lopes</surname> <given-names>S. C. P.</given-names>
</name>
<name>
<surname>Costa</surname> <given-names>F. T. M.</given-names>
</name>
<etal/>
</person-group>. (<year>2016</year>). <article-title>Rheopathologic consequence of plasmodium vivax rosette formation</article-title>. <source>PloS Negl. Trop. Dis.</source> <volume>10</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pntd.0004912</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>